JP2016502980A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016502980A5 JP2016502980A5 JP2015546771A JP2015546771A JP2016502980A5 JP 2016502980 A5 JP2016502980 A5 JP 2016502980A5 JP 2015546771 A JP2015546771 A JP 2015546771A JP 2015546771 A JP2015546771 A JP 2015546771A JP 2016502980 A5 JP2016502980 A5 JP 2016502980A5
- Authority
- JP
- Japan
- Prior art keywords
- agent according
- respiratory disease
- cells
- stro
- asthma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003795 chemical substances by application Substances 0.000 claims 15
- 208000023504 respiratory system disease Diseases 0.000 claims 13
- 208000006673 asthma Diseases 0.000 claims 7
- 230000007815 allergy Effects 0.000 claims 6
- 206010020751 Hypersensitivity Diseases 0.000 claims 5
- 239000013566 allergen Substances 0.000 claims 4
- 102100025683 Alkaline phosphatase, tissue-nonspecific isozyme Human genes 0.000 claims 3
- 101000574445 Homo sapiens Alkaline phosphatase, tissue-nonspecific isozyme Proteins 0.000 claims 3
- 208000026935 allergic disease Diseases 0.000 claims 2
- 208000028004 allergic respiratory disease Diseases 0.000 claims 2
- 230000000735 allogeneic effect Effects 0.000 claims 2
- 230000002757 inflammatory effect Effects 0.000 claims 2
- 229940125389 long-acting beta agonist Drugs 0.000 claims 2
- 230000000414 obstructive effect Effects 0.000 claims 2
- 201000004335 respiratory allergy Diseases 0.000 claims 2
- PZSMUPGANZGPBF-UHFFFAOYSA-N 4-[5-(dithiolan-3-yl)pentanoylamino]butanoic acid Chemical compound OC(=O)CCCNC(=O)CCCCC1CCSS1 PZSMUPGANZGPBF-UHFFFAOYSA-N 0.000 claims 1
- 208000014085 Chronic respiratory disease Diseases 0.000 claims 1
- 206010011968 Decreased immune responsiveness Diseases 0.000 claims 1
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 1
- 208000019693 Lung disease Diseases 0.000 claims 1
- 208000024716 acute asthma Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 208000023819 chronic asthma Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000000428 dust Substances 0.000 claims 1
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 1
- 230000004199 lung function Effects 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261736352P | 2012-12-12 | 2012-12-12 | |
| US61/736,352 | 2012-12-12 | ||
| PCT/AU2013/001454 WO2014089625A1 (en) | 2012-12-12 | 2013-12-12 | Methods of treating or preventing respiratory conditions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018055386A Division JP6665218B2 (ja) | 2012-12-12 | 2018-03-22 | 呼吸器系疾患を治療又は予防する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016502980A JP2016502980A (ja) | 2016-02-01 |
| JP2016502980A5 true JP2016502980A5 (enExample) | 2017-02-02 |
| JP6313327B2 JP6313327B2 (ja) | 2018-04-18 |
Family
ID=50933587
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015546771A Active JP6313327B2 (ja) | 2012-12-12 | 2013-12-12 | 呼吸器系疾患を治療又は予防する方法 |
| JP2018055386A Active JP6665218B2 (ja) | 2012-12-12 | 2018-03-22 | 呼吸器系疾患を治療又は予防する方法 |
| JP2020026138A Pending JP2020097618A (ja) | 2012-12-12 | 2020-02-19 | 呼吸器系疾患を治療又は予防する方法 |
| JP2022024306A Active JP7420844B2 (ja) | 2012-12-12 | 2022-02-18 | 呼吸器系疾患を治療又は予防する方法 |
| JP2024002878A Pending JP2024041904A (ja) | 2012-12-12 | 2024-01-11 | 呼吸器系疾患を治療又は予防する方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018055386A Active JP6665218B2 (ja) | 2012-12-12 | 2018-03-22 | 呼吸器系疾患を治療又は予防する方法 |
| JP2020026138A Pending JP2020097618A (ja) | 2012-12-12 | 2020-02-19 | 呼吸器系疾患を治療又は予防する方法 |
| JP2022024306A Active JP7420844B2 (ja) | 2012-12-12 | 2022-02-18 | 呼吸器系疾患を治療又は予防する方法 |
| JP2024002878A Pending JP2024041904A (ja) | 2012-12-12 | 2024-01-11 | 呼吸器系疾患を治療又は予防する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US10028979B2 (enExample) |
| EP (1) | EP2931373B1 (enExample) |
| JP (5) | JP6313327B2 (enExample) |
| KR (1) | KR101748712B1 (enExample) |
| CN (2) | CN115919901A (enExample) |
| AU (4) | AU2013360026B2 (enExample) |
| CA (1) | CA2893951C (enExample) |
| ES (1) | ES2759281T3 (enExample) |
| IL (1) | IL239309A0 (enExample) |
| SG (2) | SG10201807682PA (enExample) |
| WO (1) | WO2014089625A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2931373B1 (en) | 2012-12-12 | 2019-08-21 | Mesoblast, Inc. | Methods of treating or preventing respiratory conditions |
| WO2016049156A1 (en) * | 2014-09-23 | 2016-03-31 | Case Western Reserve University | Compositions and methods for treating lung remodeling diseases |
| BR112020004856A2 (pt) * | 2017-09-15 | 2020-09-15 | Cynata Therapeutics Limited | método para tratar doença alérgica das vias aéreas (aad)/asma |
| US20230086254A1 (en) * | 2020-01-30 | 2023-03-23 | Jcr Pharmaceuticals Co., Ltd. | Medicinal composition comprising dental pulp-derived cells |
| JP7551340B2 (ja) * | 2020-06-04 | 2024-09-17 | 株式会社三共 | 遊技機 |
| JP7551341B2 (ja) * | 2020-06-04 | 2024-09-17 | 株式会社三共 | 遊技機 |
| CN118800458B (zh) * | 2024-09-14 | 2024-11-15 | 吉林大学 | 一种心胸外科术后并发症预测方法及系统 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003901668A0 (en) * | 2003-03-28 | 2003-05-01 | Medvet Science Pty. Ltd. | Non-haemopoietic precursor cells |
| DE60314602T2 (de) * | 2002-02-19 | 2008-02-28 | Medipost, Co., Ltd. | Verfahren zur isolierung und kulturexpansion mesenchymaler stamm-/vorläuferzellen aus nabelschnurblut sowie verfahren zur differenzierung von aus nabelschnurblut stammenden mesenchymalen stamm-/vorläuferzellen in unterschiedliche mesenchymgewebe |
| US20080095749A1 (en) * | 2004-03-22 | 2008-04-24 | Sudeepta Aggarwal | Mesenchymal stem cells and uses therefor |
| US20080260694A1 (en) * | 2004-09-24 | 2008-10-23 | Angioblast Systems, Inc. | Multipotential Expanded Mesenchymal Precursor Cell Progeny (Memp) and Uses Thereof |
| KR101617319B1 (ko) * | 2005-04-12 | 2016-05-02 | 메소블라스트, 아이엔씨. | 조직 비특이적인 알카리 포스파타제에 의한 다분화성 성체 세포의 분리 |
| US20120269774A1 (en) * | 2006-09-21 | 2012-10-25 | Medistem Laboratories, Inc | Allogeneic stem cell transplants in non-conditioned recipients |
| US20090053182A1 (en) * | 2007-05-25 | 2009-02-26 | Medistem Laboratories, Inc. | Endometrial stem cells and methods of making and using same |
| ES2923016T3 (es) * | 2007-08-06 | 2022-09-22 | Mesoblast Inc | Células precursoras mesenquimales TNAP+ para el tratamiento de enfermedades del tejido conectivo |
| JP5539886B2 (ja) * | 2007-10-17 | 2014-07-02 | ティクセル | Ｔｒ１細胞、間葉系幹細胞およびその使用 |
| CN102144028B (zh) * | 2008-09-03 | 2017-12-26 | 中胚有限公司 | 造血前体的扩增 |
| KR101871472B1 (ko) * | 2010-07-02 | 2018-06-27 | 메소블라스트, 아이엔씨. | 이식편대숙주 질환의 치료 방법 |
| CN109432126B (zh) * | 2011-03-11 | 2022-06-14 | 儿童医学中心公司 | 与间充质干细胞外来体相关的方法和组合物 |
| CN109276706A (zh) * | 2011-06-03 | 2019-01-29 | 麦瑟布莱斯特公司 | 治疗或预防神经性疾病的方法 |
| EP2931373B1 (en) | 2012-12-12 | 2019-08-21 | Mesoblast, Inc. | Methods of treating or preventing respiratory conditions |
-
2013
- 2013-12-12 EP EP13862590.0A patent/EP2931373B1/en active Active
- 2013-12-12 AU AU2013360026A patent/AU2013360026B2/en active Active
- 2013-12-12 WO PCT/AU2013/001454 patent/WO2014089625A1/en not_active Ceased
- 2013-12-12 JP JP2015546771A patent/JP6313327B2/ja active Active
- 2013-12-12 CN CN202310100395.1A patent/CN115919901A/zh active Pending
- 2013-12-12 SG SG10201807682PA patent/SG10201807682PA/en unknown
- 2013-12-12 KR KR1020157017530A patent/KR101748712B1/ko active Active
- 2013-12-12 ES ES13862590T patent/ES2759281T3/es active Active
- 2013-12-12 CA CA2893951A patent/CA2893951C/en active Active
- 2013-12-12 US US14/650,171 patent/US10028979B2/en active Active
- 2013-12-12 CN CN201380072492.9A patent/CN105377274A/zh active Pending
- 2013-12-12 SG SG11201504352TA patent/SG11201504352TA/en unknown
-
2015
- 2015-06-09 IL IL239309A patent/IL239309A0/en unknown
-
2018
- 2018-03-22 JP JP2018055386A patent/JP6665218B2/ja active Active
- 2018-07-16 US US16/036,402 patent/US10688134B2/en active Active
- 2018-09-10 AU AU2018226514A patent/AU2018226514B2/en active Active
-
2020
- 2020-02-19 JP JP2020026138A patent/JP2020097618A/ja active Pending
- 2020-03-20 AU AU2020202022A patent/AU2020202022A1/en not_active Abandoned
- 2020-06-01 US US16/889,354 patent/US20200289578A1/en not_active Abandoned
-
2022
- 2022-02-18 JP JP2022024306A patent/JP7420844B2/ja active Active
- 2022-07-26 AU AU2022209219A patent/AU2022209219B2/en active Active
-
2024
- 2024-01-11 JP JP2024002878A patent/JP2024041904A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016502980A5 (enExample) | ||
| Zhong et al. | Increased innate type 2 immune response in house dust mite-allergic patients with allergic rhinitis | |
| Pappas et al. | The role of macrophages in obstructive airways disease: chronic obstructive pulmonary disease and asthma | |
| TN2012000512A1 (en) | Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies | |
| EA201591269A1 (ru) | Способы лечения аутоиммунных, респираторных и воспалительных расстройств ингаляцией n-оксида рофлумиласта | |
| UA100777C2 (ru) | Вдыхаемые частички, содержащие тиотропий | |
| RU2015143254A (ru) | Лечение заболеваний, расстройств или патологических состояний легких с использованием плацентарных клеток | |
| EA201190108A1 (ru) | Фармацевтическая композиция для ингаляции | |
| JP2008513467A5 (enExample) | ||
| PE20141012A1 (es) | Dimaleato de 9-[4-(3-cloro-2-fluoro-fenilamino)-7-metoxi-quinazolin-6-iloxi]-1,4-diaza-espiro[5.5]undecan-5-ona, su uso como medicamento y su preparacion | |
| EA201590019A1 (ru) | Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы | |
| SG10201807682PA (en) | Methods of Treating or Preventing Respiratory Conditions | |
| JP2013507945A5 (enExample) | ||
| EP2120935A4 (en) | NOVEL COMBINATION OF COMPOUNDS FOR THE TREATMENT OF AIRWAY DISEASES, IN PARTICULAR CHRONIC OBSTRUCTIVE BRONCHOPNEUMOPATHY (COPD) AND ASTHMA | |
| WO2015049519A3 (en) | Method and apparatus for making compositions for pulmonary administration | |
| EA201201393A1 (ru) | Ингалятор, разработанный для доставки лекарственного средства в виде сухого порошка | |
| UA115989C2 (uk) | Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії | |
| JP2016504311A5 (enExample) | ||
| van Echteld et al. | A view on imaging in drug research and development for respiratory diseases | |
| Nabavi et al. | Prevalence of mold allergy in patients with allergic rhinitis referred to Semnan clinic of allergy | |
| Krimmer et al. | Exposure To Biomass Smoke Extract Enhances Fibronectin Release From Human Lung Fibroblasts | |
| JP2013194009A5 (enExample) | ||
| CN201879100U (zh) | 一种桌子 | |
| Singhera et al. | Corticosteroid Exposure Alters The Airway Epithelial Response To Injury | |
| Schlaich et al. | P2y14 receptor deficiency attenuates phenotype of allergic airway inflammation in mice |